{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:21:34Z","timestamp":1777641694817,"version":"3.51.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Central nervous system metastasis in non-small cell lung cancer remains a therapeutic challenge and confers a poor prognosis. Here we describe a patient with lung adenocarcinoma, parenchymal brain metastases, and leptomeningeal carcinomatosis who demonstrated a sustained response to programmed death 1 inhibition combined with stereotactic radiosurgery.<\/jats:p>","DOI":"10.1634\/theoncologist.2018-0022","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T15:15:27Z","timestamp":1533222927000},"page":"e159-e161","source":"Crossref","is-referenced-by-count":5,"title":["Intracranial Response to Anti-Programmed Death 1 Therapy in a Patient with Metastatic Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis"],"prefix":"10.1093","volume":"23","author":[{"given":"Suneel D.","family":"Kamath","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya U.","family":"Kumthekar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Neuro-Oncology, Northwestern University, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim J.","family":"Kruser","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha A.","family":"Mohindra","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"2021122511342872800_onco12626-bib-0001","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.lungcan.2012.03.002","article-title":"Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group","volume":"77","author":"Umemura","year":"2012","journal-title":"Lung Cancer"},{"key":"2021122511342872800_onco12626-bib-0002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2017.02.022","article-title":"Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient","volume":"108","author":"Gion","year":"2017","journal-title":"Lung Cancer"},{"key":"2021122511342872800_onco12626-bib-0003","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"2021122511342872800_onco12626-bib-0004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"2021122511342872800_onco12626-bib-0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: Early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol"},{"issue":"suppl 15","key":"2021122511342872800_onco12626-bib-0006","doi-asserted-by":"crossref","first-page":"9507a","DOI":"10.1200\/JCO.2017.35.15_suppl.9507","article-title":"Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204","volume":"35","author":"Tawbi","year":"2017","journal-title":"JClin Oncol"},{"key":"2021122511342872800_onco12626-bib-0007","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"2021122511342872800_onco12626-bib-0008","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdx700","article-title":"Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small cell lung cancer","volume":"29","author":"Otsubo","year":"2018","journal-title":"Ann Oncol"},{"key":"2021122511342872800_onco12626-bib-0009","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/1078-0432.CCR-15-1836","article-title":"Alterations in pericyte subpopulations are associated with elevated blood\u2013tumor barrier permeability in experimental brain metastasis of breast cancer","volume":"22","author":"Lyle","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2021122511342872800_onco12626-bib-0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.lungcan.2016.05.031","article-title":"Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases","volume":"98","author":"Dudnik","year":"2016","journal-title":"Lung Cancer"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2018-0022","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2018-0022","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/23\/12\/e159\/41915151\/oncolo_23_12_e159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/23\/12\/e159\/41915151\/oncolo_23_12_e159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T11:35:29Z","timestamp":1640432129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/23\/12\/e159\/6439905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":10,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,8,2]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2018-0022","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,1]]},"published":{"date-parts":[[2018,8,2]]}}}